Epicentre   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Paris France (1986)
Status: Acquired by Illumina, Inc. (2011)

Organization Overview

First Clinical Trial
2001
NCT00330148
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Epicentre | Epicentre, Paris, France.